A M I No. 16.14/2025 26 Cetuximab Inj 100mg
Tender Title | A M I No. 16.14/2025 26 Cetuximab Inj 100mg | ||
Tender ID | NA | Tender Reference Number | 82251027 |
Tender Type | Open/advertised | ||
Tender Opening Date | 2025-01-22 10:46 AM | Tender Closing Date | 2025-02-24 05:30 AM |
Tender Value | Refer Document | Tender Location | New Delhi , Central Delhi , Delhi |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2025-01-22 10:46 AM | Bid Opening Date | 2025-02-24 05:30 AM |
Document Download Start Date | 2025-01-22 10:46 AM | Document Download End Date | 2025-02-24 05:30 AM |
Bid Submission Start Date | 2025-01-22 10:46 AM | Bid Submission End Date | 2025-02-24 05:30 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | ₹ 1,06,250 |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, Stores/Northern Railway (2nd Floor, Annexe-I Baroda House, KG Marg, New Delhi), invites tenders for the supply of Cetuximab Inj 100mg (A.M.I. No. 16.14/2025-26) under Tender Reference Number 82251027. This open tender for railway-related goods requires a bid security of ₹106,250, with no tender fee. Interested bidders can download tender documents from January 22nd, 2025, 4:16 PM to February 24th, 2025, 11:00 AM. Bid submission opens on January 22nd, 2025, 4:16 PM and closes on February 24th, 2025, 11:00 AM, with bids opening at the same time on the latter date. For complete details, refer to the tender document.
Get Hassle free financing for your business
Office Inviting Bids | Stores/northern Rly |
Address | 2nd Floor, Annexe- I Baroda House, K G Marg New Delhi |
Contact Details | NA |
NA | |
Website | NA |
A M I No - 16.15/2025-26 Cetuximab Inj 500mg..read more
A M I No - 16.64/-2025-26 Pembrolizumab Inj 100mg..read more
A M I No - 16.59/2025-26 Paclitaxel Albubound Inj 100mg With..read more
A M I No -gr. 16 N 16/2025-26 Trastuzumab Deruxtecan Inj..read more
A M I No. 2025-26 Tab./cap. Lorlatinib 100mg..read more
All the major brands in each raw material category